Intranasal drug slows MS progression in mice studyPublished: 22 October 2020 A new study has found that an anti-inflammatory drug administered nasally may reduce the progression of multiple sclerosis (MS) in mice.  Researchers focused on molecules called inflammasomes which are responsible for the activation of the inflammatory response in the